摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

N-benzyl-N'-[quinolin-6-yl]urea | 608516-65-0

中文名称
——
中文别名
——
英文名称
N-benzyl-N'-[quinolin-6-yl]urea
英文别名
1-benzyl-3-quinolin-6-ylurea
N-benzyl-N'-[quinolin-6-yl]urea化学式
CAS
608516-65-0
化学式
C17H15N3O
mdl
——
分子量
277.326
InChiKey
ZDUKJAQBBNETOE-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.9
  • 重原子数:
    21
  • 可旋转键数:
    3
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.06
  • 拓扑面积:
    54
  • 氢给体数:
    2
  • 氢受体数:
    2

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    N-benzyl-N'-[quinolin-6-yl]urea盐酸 、 palladium on carbon 、 氢气 作用下, 以 甲醇 为溶剂, 20.0 ℃ 、101.33 kPa 条件下, 反应 20.0h, 以99 mg的产率得到1-(quinolin-6-yl)urea
    参考文献:
    名称:
    Synthesis of Unsymmetrical Diarylureas via Pd-Catalyzed C–N Cross-Coupling Reactions
    摘要:
    A facile synthesis of unsymmetrical N,N'-diarylureas is described. The utilization of the Pd-catalyzed arylation of ureas enables the synthesis of an array of diarylureas in good to excellent yields from benzylurea via a one-pot arylation-deprotection protocol, followed by a second arylation.
    DOI:
    10.1021/ol201210t
  • 作为产物:
    描述:
    参考文献:
    名称:
    Synthesis of Unsymmetrical Diarylureas via Pd-Catalyzed C–N Cross-Coupling Reactions
    摘要:
    A facile synthesis of unsymmetrical N,N'-diarylureas is described. The utilization of the Pd-catalyzed arylation of ureas enables the synthesis of an array of diarylureas in good to excellent yields from benzylurea via a one-pot arylation-deprotection protocol, followed by a second arylation.
    DOI:
    10.1021/ol201210t
点击查看最新优质反应信息

文献信息

  • Heteroaromatic urea derivatives as vr-1receptor modulators for treating pain
    申请人:Brown Elizabeth Rebecca
    公开号:US20050107388A1
    公开(公告)日:2005-05-19
    The present invention provides compounds of formula (I); pharmaceutically acceptable salts and N-oxides thereof in which A, B, D and E are C or N with the proviso that one or more are N, R 1 , R 2 , R 3 , R 4 , R 5 and R 6 are simple substituents, n is 0-3 and y is an aryl, heteroaryl, carbocyclyl or fused-carbocyclyl group; as VR-1 antagonists for treating conditions or diseases in which pain and/or inflammation predominates; the use of the same for manufacturing medicaments, pharmaceutical compositions comprising them and methods of treatment utilising them.
    本发明提供了式(I)的化合物;其药学上可接受的盐和N-氧化物,其中A,B,D和E是C或N,但其中一个或多个是N,R1,R2,R3,R4,R5和R6是简单的取代基,n是0-3,y是芳基,杂环芳基,碳环芳基或融合的碳环芳基基团;作为VR-1拮抗剂,用于治疗疼痛和/或炎症占优势的疾病或症状;同样的用于制造药物、包含它们的制剂和利用它们的治疗方法。
  • Heteroaromatic urea derivatives as VR-1 receptor modulators for treating pain
    申请人:——
    公开号:US07285563B2
    公开(公告)日:2007-10-23
    The present invention provides compounds of formula (I); pharmaceutically acceptable salts and N-oxides thereof in which A, B, D and E are C or N with the proviso that one or more are N, R1, R2, R3, R4, R5 and R6 are simple substituents, n is 0-3 and y is an aryl, heteroaryl, carbocyclyl or fused-carbocyclyl group; as VR-1 antagonists for treating conditions or diseases in which pain and/or inflammation predominates; the use of the same for manufacturing medicaments, pharmaceutical compositions comprising them and methods of treatment utilizing them
    本发明提供了式(I)的化合物;其药学上可接受的盐和N-氧化物,其中A、B、D和E是C或N,但至少一个是N,R1、R2、R3、R4、R5和R6是简单的取代基,n为0-3,y是芳香基,杂环芳基,碳环基或融合碳环基;作为VR-1拮抗剂,用于治疗疼痛和/或炎症占优势的疾病或症状;将其用于制造药物,制备包含它们的制药组合物和利用它们的治疗方法。
  • US7285563B2
    申请人:——
    公开号:US7285563B2
    公开(公告)日:2007-10-23
  • Synthesis of Unsymmetrical Diarylureas via Pd-Catalyzed C–N Cross-Coupling Reactions
    作者:Simon Breitler、Nathan J. Oldenhuis、Brett P. Fors、Stephen L. Buchwald
    DOI:10.1021/ol201210t
    日期:2011.6.17
    A facile synthesis of unsymmetrical N,N'-diarylureas is described. The utilization of the Pd-catalyzed arylation of ureas enables the synthesis of an array of diarylureas in good to excellent yields from benzylurea via a one-pot arylation-deprotection protocol, followed by a second arylation.
查看更多